tldrdailynews.com logo

Insmed Stock Surges on Positive Pulmonary Hypertension Trial Results

1 min read
Source: Seeking Alpha
Insmed Stock Surges on Positive Pulmonary Hypertension Trial Results
Photo: Seeking Alpha
TL;DR

Insmed's experimental therapy for pulmonary arterial hypertension succeeded in a mid-stage trial, causing shares of competitors Liquidia and United Therapeutics to fall in premarket trading.

Topics:businesshealthcare#healthcare#insmed#liquidia#mid-stage-trial#pulmonary-arterial-hypertension#united-therapeutics
Share this article
  1. Liquidia stock, United Therapeutics stock fall on Insmed data  Seeking Alpha
  2. Insmed Stock Soars on Pulmonary Arterial Hypertension Drug Trial Results  Yahoo Finance
  3. Insmed's 'unprecedented' phase 2 PAH win sends stocks soaring as the race to phase 3 kicks off  Fierce Pharma
  4. Biotech Hits A 'Home Run' And Slams Its Two Key Rivals  Investor's Business Daily
  5. Insmed Stock Soars on Experimental Hypertension Drug Trial Results  Barron's

Want the full story? Read the original reporting

Read on Seeking Alpha